{"id":16410,"date":"2021-01-05T01:25:03","date_gmt":"2021-01-04T22:25:03","guid":{"rendered":"https:\/\/www.klimikdergisi.org\/\/2021\/01\/05\/pegylated-interferon-and-ribavirin-treatment-of-chronic-hepatitis-c-coinfection-in-a-patient-with-human-immunodeficiency-virus-infection\/"},"modified":"2021-01-05T01:25:03","modified_gmt":"2021-01-04T22:25:03","slug":"pegylated-interferon-and-ribavirin-treatment-of-chronic-hepatitis-c-coinfection-in-a-patient-with-human-immunodeficiency-virus-infection","status":"publish","type":"post","link":"https:\/\/www.klimikdergisi.org\/en\/2021\/01\/05\/pegylated-interferon-and-ribavirin-treatment-of-chronic-hepatitis-c-coinfection-in-a-patient-with-human-immunodeficiency-virus-infection\/","title":{"rendered":"Pegylated Interferon and Ribavirin Treatment of Chronic Hepatitis C Coinfection in a Patient with Human Immunodeficiency Virus Infection"},"content":{"rendered":"<h1>Abstract<\/h1>\n<p> Human immunodeficiency virus (HIV) and hepatitis C virus (HCV) coinfection is seen frequently due to similar routes of transmission. In coinfected patients, progression of chronic hepatitis C (CHC) infection is accelerated. In this study, a 44-year old male patient with HIV\/HCV (genotype 1b) coinfection is evaluated. For the treatment of CHC, pegylated interferon alpha 2a 180 mg per week and ribavirin 1000 mg\/day were used for 48 weeks and sustained virologic response was achieved. During the course of CHC treatment no adverse effect was seen.\u00a0<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Abstract Human immunodeficiency virus (HIV) and hepatitis C virus (HCV) coinfection is seen frequently due to similar routes of transmission. In coinfected patients, progression of chronic hepatitis C (CHC) infection is accelerated. In this study, a 44-year old male patient with HIV\/HCV (genotype 1b) coinfection is evaluated. For the treatment of CHC, pegylated interferon alpha [&hellip;]<\/p>\n","protected":false},"author":0,"featured_media":0,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[5132],"tags":[4079,4077,3228,4081,3874],"class_list":["post-16410","post","type-post","status-publish","format-standard","hentry","category-case-report","tag-coinfection","tag-hcv-antibodies","tag-hiv","tag-pegylated-interferon-alpha-2a","tag-ribavirin"],"acf":[],"_links":{"self":[{"href":"https:\/\/www.klimikdergisi.org\/en\/wp-json\/wp\/v2\/posts\/16410","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.klimikdergisi.org\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.klimikdergisi.org\/en\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/www.klimikdergisi.org\/en\/wp-json\/wp\/v2\/comments?post=16410"}],"version-history":[{"count":0,"href":"https:\/\/www.klimikdergisi.org\/en\/wp-json\/wp\/v2\/posts\/16410\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.klimikdergisi.org\/en\/wp-json\/wp\/v2\/media?parent=16410"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.klimikdergisi.org\/en\/wp-json\/wp\/v2\/categories?post=16410"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.klimikdergisi.org\/en\/wp-json\/wp\/v2\/tags?post=16410"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}